Urology
Audio Summaries

Predictors of Perceived Sports Performance in Female Athletes: The Role of Pelvic Floor Dysfunction and Sleep Quality

This study investigates the relationships between perceived sports performance (PSP), pelvic floor dysfunction (PFD), and sleep quality in female athletes, aiming to determine whether PFD and sleep quality are independent predictors of PSP. The findings indicate that pelvic organ prolapse symptoms significantly predict certain aspects of PSP, while sleep quality does not emerge as a significant predictor. The authors suggest further research to explore the potential benefits of integrating pelvic health screenings into athletic training routines.

Efficacy and safety of tirofiban after successful endovascular reperfusion in acute ischaemic stroke (ATTRACTION) in China: a multicentre, double-blind, randomised controlled trial

The authors aimed to evaluate the efficacy and safety of tirofiban, a glycoprotein IIb/IIIa receptor antagonist, in improving functional independence in patients with acute ischaemic stroke following successful endovascular reperfusion. In a multicentre, double-blind, randomized controlled trial involving 1,380 patients, tirofiban was found to significantly increase the likelihood of functional independence at 90 days compared to placebo, although there was no significant difference in the rates of symptomatic intracranial hemorrhage or mortality between the two groups.

Self-Directed vs Clinician-Delivered Cognitive Behavioral Therapy for Chronic Pain: A Randomized Clinical Trial

The authors aimed to compare the effectiveness of self-directed cognitive behavioral therapy for chronic pain (CBT-CP) with asynchronous feedback to clinician-delivered CBT-CP in patients with chronic musculoskeletal pain. The study found that self-directed CBT-CP significantly reduced pain interference and improved secondary outcomes at 4 months, with benefits sustained at 12 months, suggesting it may be a more accessible alternative to traditional clinician-delivered therapy.

Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas

The authors aimed to evaluate the long-term outcomes of anti-CD19 CAR T-cell therapy (tisagenlecleucel) in patients with relapsed or refractory B-cell non-Hodgkin lymphomas over a median follow-up of 10.1 years. They found that approximately 32% of patients with large B-cell lymphoma and 47% with follicular lymphoma achieved lymphoma-free survival, with a notable persistence of B-cell aplasia in long-term responders. The study highlights the potential for durable remissions in this patient population, despite some risks of non-relapse-related mortality and secondary cancers.

A Pragmatic Trial of a 6-Month Strategy for Rifampicin-Resistant Tuberculosis

The authors aimed to evaluate the efficacy and safety of a 6-month treatment regimen for pulmonary rifampicin-resistant tuberculosis compared to the standard 9-month treatment in South Africa. The study found that the 6-month regimen was noninferior in achieving successful treatment outcomes and had a similar safety profile to the standard regimen. This suggests that the shorter treatment duration may be a viable alternative for managing rifampicin-resistant tuberculosis.

Prevention and Treatment of Peanut Allergy

This paper investigates the effectiveness of early peanut protein introduction and immunotherapy in preventing and treating peanut allergy. The authors find that introducing peanut protein early significantly reduces allergy prevalence, with optimal prevention strategies differing for low and high-risk infants. Additionally, they highlight that immunotherapy is more effective when started in younger children, emphasizing the critical need for early intervention.

Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a study

This study aimed to evaluate the safety, tolerability, and preliminary efficacy of AC01, an oral ghrelin receptor agonist, in patients with heart failure with reduced ejection fraction (HFrEF). The results indicated that AC01 was generally safe and well tolerated over 28 days, with no major adverse events reported, suggesting potential for further investigation in larger trials.

Postoperative Mobility After Partial Semitendinosus Tendon Harvesting in Pelvic Organ Prolapse Surgery: Results of a Prospective Observational Study

This study aimed to evaluate the impact of partial semitendinosus tendon harvesting during pelvic organ prolapse surgery on postoperative mobility and to identify patient-related factors influencing mobility outcomes. The findings indicate that the procedure does not impair mobility and is associated with significant improvements in function and quality of life, although older age and higher BMI are linked to lower mobility potential. Overall, the majority of patients reported high satisfaction with the procedure.

Content Validity of Measurement Instruments Used to Assess Patient Quality of Life (QoL) in Women with Stress Urinary Incontinence: A Systematic Review

The authors aimed to evaluate the content validity of patient-reported outcome measures (PROMs) used to assess quality of life in women with stress urinary incontinence (SUI). Their systematic review found that the methodological quality of most PROMs was inadequate, with limited patient involvement in their development, leading to heterogeneous and often insufficient evidence supporting their content validity. The study highlights the need for improved adherence to established guidelines to ensure these instruments effectively capture outcomes relevant to patients.

Combined bladder-kidney transplantation: first-in-human feasibility trial

The authors investigate the feasibility and safety of combined bladder-kidney transplantation as a novel treatment for patients with terminal bladder dysfunction and end-stage kidney disease. The first-in-human trial demonstrated successful surgical outcomes, with the patient maintaining good renal and bladder function, sensation, and continence beyond six months post-transplantation, suggesting this approach may be a viable option for select patients requiring immunosuppression.